Postes actifs de Bruno Wohlschlegel
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| APONTIS PHARMA AG | Directeur Général | - | - |
Apontis Pharma GmbH & Co. KG
 Apontis Pharma GmbH & Co. KG Pharmaceuticals: MajorHealth Technology APONTIS PHARMA Deutschland GmbH & Co. KG engages in the wholesale of pharmaceutical products. It focuses on medicines used for the treatment of chronic obstructive pulmonary diseases, hypertension, and cardiovascular diseases. The company was founded on February 13, 2015 and is headquartered in Monheim, Germany. | Directeur Général | 01/09/2023 | - |
Historique de carrière de Bruno Wohlschlegel
Statistiques
Internationale
| Allemagne | 3 |
Opérationnelle
| Chief Executive Officer | 2 |
Sectorielle
| Health Technology | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| APONTIS PHARMA AG | Health Technology |
| Entreprise privées | 1 |
|---|---|
Apontis Pharma GmbH & Co. KG
Apontis Pharma GmbH & Co. KG Pharmaceuticals: MajorHealth Technology APONTIS PHARMA Deutschland GmbH & Co. KG engages in the wholesale of pharmaceutical products. It focuses on medicines used for the treatment of chronic obstructive pulmonary diseases, hypertension, and cardiovascular diseases. The company was founded on February 13, 2015 and is headquartered in Monheim, Germany. | Health Technology |
- Bourse
- Insiders
- Bruno Wohlschlegel
- Expérience
